Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
Bionano Genomics (Nasdaq: BNGO) will report fourth quarter and full year 2025 financial results and host a conference call and live webcast on Monday, March 23, 2026 at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bionano Genomics (Nasdaq: BNGO) will report fourth quarter and full year 2025 financial results and host a conference call and live webcast on Monday, March 23, 2026 at 4:30 p.m. ET.
Participants can access the live webcast via the company’s Investors page; a replay will be archived on the investor relations site for at least 30 days. Contact details and registration links are provided for investors and media.
Details
News Market Reaction – BNGO
On Mar 10, the first trading day after this news, BNGO closed 0.89% above the previous close.
Data tracked by StockTitan Argus for the Mar 10 session.
Key Figures
- Earnings call date
- March 23, 2026
- Scheduled conference call and webcast
- Earnings call time
- 4:30 p.m. ET
- Start time of Q4 and full-year 2025 call
- Webcast archive duration
- 30 days
- Replay availability on investor relations website
- Current share price
- $1.11
- Price prior to earnings-date news
- 52-week range
- $1.06 – $5.50
- Position near low, far below high
- Market capitalization
- $11,498,880
- Equity value before earnings-date announcement
- 20-day avg volume
- 131,182 shares
- Baseline for current trading activity
- Replay website duration
- At least 30 days
- Conference call replay period on IR site
Historical Context
-
Day 4 Symposium 2026 recap with 35 speakers, 33 presentations and 50 posters.
-
Day 3 presentations on OGM in constitutional genetic disorders and strong global attendance.
-
Day 2 focus on oncology and cell & gene therapy applications of optical genome mapping.
-
Day 1 coverage of OGM for hematologic malignancies and high global participation.
-
Announcement of free virtual Bionano Symposium 2026 featuring 30+ researchers and OGM demos.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress.
Conference Call & Webcast Details
| Date: | Monday, March 23rd, 2026 |
| Time: | 4:30 p.m. ET |
| Participant Link: | Registration – Click here |
| Webcast Link: | Registration – Click here |
Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Webb Campbell
Gilmartin Group
+1 (415) 520-5817
IR@bionano.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.